Status:
COMPLETED
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
Lead Sponsor:
NYU Langone Health
Conditions:
Multiple Myeloma
Disease of the Marrow
Eligibility:
All Genders
30-80 years
Brief Summary
Developing an MRI protocol at 1.5 T allowing quantification of the hematopoietic, fatty and trabecular moieties of marrow. An ideal protocol would differentiate red marrow from neoplastic cellular inf...
Detailed Description
Imaging of the pelvis and bilateral femora at 1.5 Tesla in a 30 minute research time "slots" at NYU-FPO MRI, Tisch Hospital, NYU Medical Center, Department of Radiology, HCC basement. This protocol ut...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- subjects who are schedule for PET CT
- subjects that are diagnosed with Multiple Myeloma.
- Healthy subjects will be enrolled to optimize imaging techniques
- subjects 30 - 80 years of age
- Exclusion Criteria:
- Exclusion criteria include all patients who are contraindicated for MR imaging in general.
- Contraindications include:
- electrical implants such as cardiac pacemakers or perfusion pumps
- ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants
- ferromagnetic objects such as jewelry or metal clips in clothing
- pregnant subjects
- pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions, and any greater than normal potential for cardiac arrest.
Exclusion
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01880762
Start Date
January 1 2013
End Date
December 1 2016
Last Update
December 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Center for Biomedical Imaging
New York, New York, United States, 10016